Kevin M Page

Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics.

B. Blough, R. Rothman, J. Partilla, 2014, ACS medicinal chemistry letters.

Alpha-ethyltryptamines as dual dopamine-serotonin releasers.

B. Blough, R. Rothman, J. Partilla, 2014, Bioorganic & medicinal chemistry letters.

Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.

S. Mascarella, B. Thomas, M. Brackeen, 2008, Journal of medicinal chemistry.

Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight 'molecular budget'.

P. Thomas, Jonathan D Goodacre, Lena Shukla, 2020, Bioorganic & medicinal chemistry letters.

Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.

H. Navarro, F. Carroll, Chunyang Jin, 2008, Bioorganic & medicinal chemistry.

Conformational characteristics of the interaction of SR141716A with the CB1 cannabinoid receptor as determined through the use of conformationally constrained analogs

B. Thomas, M. Brackeen, H. Seltzman, 2006, The AAPS Journal.